Inactive Instrument
Quest PharmaTech Inc Stock Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.44M 2.1M 1.98M 1.81M 231M 3.39M 23.39M 9.08M 118M 9.18M 8.98M 382M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.16M 2.72M 2.56M 2.34M 298M 4.38M 30.21M 11.72M 153M 11.86M 11.6M 493M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 2.44M | |
| -2.54% | -2.84% | -1.77% | +14.33% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +46.82% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.83% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.83% | +0.53% | +74.05% | +110.25% | 30.55B | |
| Weighted average by Cap. | -1.03% | +0.11% | +89.42% | +128.98% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.3M -1.12M -1.05M -963K -123M -1.81M -12.45M -4.83M -63.06M -4.89M -4.78M -203M | 5M 3.61M 3.11M 2.92M 2.67M 341M 5.01M 34.56M 13.41M 175M 13.57M 13.27M 564M |
| Net Debt | 795K 575K 494K 465K 425K 54.25M 797K 5.5M 2.13M 27.83M 2.16M 2.11M 89.66M | 986K 712K 613K 577K 527K 67.26M 988K 6.82M 2.64M 34.51M 2.68M 2.62M 111M |
Employees
-
